Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | environmental violation | 2011 | EPA | $300,000 |
St. Jude Medical Inc. | Abbott Laboratories | kickbacks and bribery | 2011 | DOJ_CIVIL | $16,000,000 |
Johnson & Johnson | Johnson & Johnson | Foreign Corrupt Practices Act | 2011 | DOJ_CRIMINAL | $21,400,000 |
Johnson & Johnson | Johnson & Johnson | Foreign Corrupt Practices Act | 2011 | SEC | $48,600,000 |
Serono Laboratories Inc. | Merck KGaA (EMD) | False Claims Act and related | 2011 | DOJ_CIVIL | $44,300,000 |
Sandoz, Inc. | Novartis | HHS civil monetary penalties | 2011 | HHSOIG | $230,000 |
AstraZeneca | AstraZeneca | employment discrimination | 2011 | OFCCP | $250,000 |
CHEROKEE PHARMACEUTICALS LLC | Merck | benefit plan administrator violation | 2011 | EBSA | $10,001 |
Block Drug Company Incorporated | GlaxoSmithKline | wage and hour violation | 2011 | WHD | $352,773 |
Amgen, Inc. | Amgen | labor relations violation | 2011 | NLRB | $40,000 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2011 | USAO | $1,725,000 |
SIGMA-ALDRICH | Merck KGaA (EMD) | aviation safety violation | 2011 | FAA | $30,000 |
Amphastar Pharmaceuticals | Amphastar Pharmaceuticals | wage and hour violation | 2011 | CA-LCO | $25,000 |
Genentech | Roche | wage and hour violation | 2011 | private lawsuit-state | $2,600,000 |
Merck & Co., Inc. | Merck | benefit plan administrator violation | 2011 | private lawsuit-federal | $49,500,000 |
Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | TX-AG | $29,230,000 |
Alpharma USPD, Inc. and Purepac Pharmaceutical Co. | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | KY-AG | $10,200,000 |
Alpharma USPD, Inc., | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
AstraZeneca Pharmaceuticals | AstraZeneca | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | $68,500,000 |
AstraZeneca Pharmaceuticals LP and AstraZeneca LP | AstraZeneca | False Claims Act and related | 2011 | ID-AG | $2,500,000 |
Boehringer Ingleheim | Boehringer Ingelheim | False Claims Act and related | 2011 | KS-AG | $1,400,000 |
Dey Pharmaceuticals | Viatris | False Claims Act and related | 2011 | PA-AG | $2,000,000 |
EMD Serono, Inc. | Merck KGaA (EMD) | False Claims Act and related | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $44,300,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2011 | KS-AG | $4,250,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | drug or medical equipment safety violation | 2011 | MULTI-AG | $40,750,000 |
Johnson & Johnson | Johnson & Johnson | False Claims Act and related | 2011 | ID-AG | $2,000,000 |
Merck & Co., Inc. | Merck | False Claims Act and related | 2011 | MA-AG | $24,000,000 |
Merck and Company, Inc. | Merck | False Claims Act and related | 2011 | WI-AG | $4,250,000 |
Merck Sharp & Dohme Corp. | Merck | False Claims Act and related | 2011 | ID-AG | $1,600,000 |
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. | Viatris | False Claims Act and related | 2011 | KY-AG | $6,500,000 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,574,209 |
Par Pharmaceutical Co. | Endo International | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Par Pharmaceutical Cos., Inc. | Endo International | False Claims Act and related | 2011 | ID-AG | $1,700,000 |
Par Pharmaceutical Inc. | Endo International | False Claims Act and related | 2011 | KY-AG | $4,500,000 |
Par Pharmaceuticals, Inc. | Endo International | False Claims Act and related | 2011 | MULTI-AG | $154,000,000 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,621,154 |
Pharmacia Corporation | Pfizer | False Claims Act and related | 2011 | NY-AG | $2,500,000 |
Purepac Pharmaceutical Co., n/k/a Actavis Elizabeth, LLC | Pfizer | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Sandoz, Inc. | Novartis | False Claims Act and related | 2011 | MS-AG | $30,110,618 |
TAP Pharmaceutical Products | Takeda Pharmaceutical | False Claims Act and related | 2011 | PA-AG | $5,240,797 |
UCB Inc. | UCB | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,893,322 |
Warrick Pharmaceuticals Corp. and Schering-Plough Corp. | Merck | False Claims Act and related | 2011 | ID-AG | $750,000 |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | MULTI-AG | $70,000,000 |
Watson/Schein Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2011 | TX-AG | $11,300,000 |
Schering-Plough Healthcare Products Inc. | Merck | environmental violation | 2011 | CA-DPR | $28,400 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | environmental violation | 2011 | CT-ENV | $20,000 |
Mallinckrodt/Covidien | Mallinckrodt | environmental violation | 2011 | MO-ENV | $6,000 |
AMNEAL PHARMACEUTICALS | Amneal Pharmaceuticals | environmental violation | 2011 | NJ-ENV | $25,000 |
PHIBRO-TECH, INC | Phibro Animal Health | environmental violation | 2011 | SC-ENV | $15,000 |
Abbott Cardiovascular Systems, Inc. | Abbott Laboratories | environmental violation | 2011 | CA-SCAQMD | $12,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $52,000,000 |
Abbott Laboratories | AbbVie | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Actavis Mid-Atlantic LLC | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $118,614,000 |
Amgen Inc. | Amgen | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $13,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $90,000,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $3,500,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $19,000,000 |
Dey, Inc. | Viatris | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Fujisawa Healthcare, Inc. | Astellas Pharma | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
GlaxoSmithKline PLC | GlaxoSmithKline | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $49,000,000 |
Hoechst Marion Roussel | Sanofi | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Immunex Corporation | Amgen | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Mylan Inc. | Viatris | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $65,000,000 |
Pharmacia Corporation | Pfizer | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Sandoz Inc. | Novartis | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $150,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $27,000,000 |
ZLB Behring, L.L.C. | CSL Limited | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
BAXTER HEALTHCARE CORP DBA BAXTER BIOSCIENCE | Takeda Pharmaceutical | workplace safety or health violation | 2011 | OSHA | $195,000 |
Schering-Plough Products, LLC | Merck | environmental violation | 2011 | EPA | $260,000 |
Roche Molecular Systems, Inc. | Roche | environmental violation | 2011 | EPA | $90,000 |
MERCK & CO., INC. | Merck | environmental violation | 2011 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,500,000 |
ELI LILLY AND COMPANY | Eli Lilly | environmental violation | 2011 | EPA | $337,500 |
ABBOTT LABS - N. CHICAGO PLANT | AbbVie | environmental violation | 2011 | EPA | $135,756 |
BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | environmental violation | 2011 | EPA | $900,000 |
Elan Corporation PLC | Perrigo | off-label or unapproved promotion of medical products | 2010 | FDA | $203,000,000 |
Eisai Inc. | Eisai | off-label or unapproved promotion of medical products | 2010 | FDA | $11,000,000 |
SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | drug or medical equipment safety violation | 2010 | FDA | $750,000,000 |
Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | FDA | $422,500,000 |
Allergan Inc. | AbbVie | off-label or unapproved promotion of medical products | 2010 | FDA | $600,000,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | off-label or unapproved promotion of medical products | 2010 | FDA | $81,000,000 |
AstraZeneca LP | AstraZeneca | off-label or unapproved promotion of medical products | 2010 | FDA | $520,000,000 |
Kos Pharmaceuticals | AbbVie | kickbacks and bribery | 2010 | FDA | $41,500,000 |
Dey Inc. | Viatris | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Roxane Laboratories Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Abbott Laboratories Inc. | AbbVie | False Claims Act and related | 2010 | DOJ_CIVIL | $126,500,000 |
St. Jude Medical Inc. | Abbott Laboratories | False Claims Act and related | 2010 | DOJ_CIVIL | $3,725,000 |
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation | Novartis | off-label or unapproved promotion of medical products | 2010 | FDA | $72,500,000 |
Schwarz Pharma Inc. | UCB | False Claims Act and related | 2010 | DOJ_CIVIL | $22,000,000 |
Alpharma Inc. | Pfizer | False Claims Act and related | 2010 | DOJ_CIVIL | $42,500,000 |
Eon Labs Inc. | Novartis | False Claims Act and related | 2010 | DOJ_CIVIL | $3,500,000 |
Synthes Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2010 | USAO | $669,800 |
Forest Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2010 | USAO | $149,000,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | drug or medical equipment safety violation | 2010 | USAO | $6,140,000 |
ETHICON ENDO SURGERY | Johnson & Johnson | aviation safety violation | 2010 | FAA | $5,500 |
ALDRICH CHEMICAL | Merck KGaA (EMD) | aviation safety violation | 2010 | FAA | $6,500 |
MILLIPORE CORPORATION | Merck KGaA (EMD) | aviation safety violation | 2010 | FAA | $15,000 |
Novartis Corporation | Novartis | employment discrimination | 2010 | private lawsuit-federal | $175,000,000 |
Sanofi-Aventis U.S. LLC | Sanofi | employment discrimination | 2010 | private lawsuit-federal | $15,360,000 |